Michele Seah - SCI Pharmtech VP

All Insiders . Taiwan . 
Stock . SCI Pharmtech . Stakeholders . Insider . Michele Seah
4119 Stock  TWD 95.50  2.10  2.15%   

Insider

Michele Seah is VP of SCI Pharmtech
Phone886 3 354 3133
Webhttps://www.sci-pharmtech.com.tw

SCI Pharmtech Management Efficiency

SCI Pharmtech's management efficiency ratios could be used to measure how well SCI Pharmtech manages its routine affairs as well as how well it operates its assets and liabilities.
SCI Pharmtech has accumulated 3.65 M in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. SCI Pharmtech has a current ratio of 3.18, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist SCI Pharmtech until it has trouble settling it off, either with new capital or with free cash flow. So, SCI Pharmtech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SCI Pharmtech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SCI to invest in growth at high rates of return. When we think about SCI Pharmtech's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

YinTeng ChangAdimmune Corp
N/A
Jason ChenScinoPharm Taiwan
N/A
MBA MDAdimmune Corp
N/A
ChinTsai FanStandard Chemical Pharmaceutica
N/A
ChiHsien ChanAdimmune Corp
N/A
BS MSScinoPharm Taiwan
N/A
TzuTing FanStandard Chemical Pharmaceutica
N/A
ChihHsiang LengAdimmune Corp
N/A
Reynold HsuStandard Chemical Pharmaceutica
N/A
MingCheng ChangExcelsior Medical Co
N/A
Shun LinScinoPharm Taiwan
N/A
LiChiao ChemistryScinoPharm Taiwan
N/A
ChihHui LinScinoPharm Taiwan
N/A
LiYa TangAdimmune Corp
N/A
LingHsiao LienScinoPharm Taiwan
N/A
ChengHsiao ChouExcelsior Medical Co
N/A
ChungCheng LiuAdimmune Corp
N/A
ChinChuan ChangAdimmune Corp
N/A
SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and specialty chemicals in Taiwan. SCI Pharmtech, Inc. was founded in 1987 and is based in Taoyuan City, Taiwan. SCI PHARMTECH operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange. SCI Pharmtech (4119) is traded on Taiwan Stock Exchange in Taiwan and employs 14 people.

Management Performance

Return On Equity0.0609
Return On Asset0.0077

SCI Pharmtech Leadership Team

Elected by the shareholders, the SCI Pharmtech's board of directors comprises two types of representatives: SCI Pharmtech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SCI. The board's role is to monitor SCI Pharmtech's management team and ensure that shareholders' interests are well served. SCI Pharmtech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SCI Pharmtech's outside directors are responsible for providing unbiased perspectives on the board's policies.
JunBang Ye, VP
WenChih Chou, GM Pres
Deiter Yang, CG Sec
Michele Seah, VP
Ricky Liu, Sustainable Mang

SCI Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SCI Pharmtech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0609
Return On Asset0.0077
Profit Margin0.26 %
Operating Margin0.07 %
Current Valuation9.19 B
Shares Outstanding95.38 M
Shares Owned By Insiders48.80 %
Shares Owned By Institutions0.77 %
Price To Earning14.98 X
Price To Book2.62 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for SCI Stock Analysis

When running SCI Pharmtech's price analysis, check to measure SCI Pharmtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCI Pharmtech is operating at the current time. Most of SCI Pharmtech's value examination focuses on studying past and present price action to predict the probability of SCI Pharmtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCI Pharmtech's price. Additionally, you may evaluate how the addition of SCI Pharmtech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY